Top 12 Clinical Research Organisations (CROs) in 2023
WEBFeb 23, 2023 · The global clinical trials market was estimated to be worth $38.7 billion in 2021 and is expected to reach £52 billion by 2026. In this article, we look at the top 12 CROs in the world, highlighting the companies driving this considerable growth and accelerating research and development across the globe.. ICON. Recognised as the world’s largest and most comprehensive CRO powered by ...
Top Ten Pharmaceutical Companies in Australia - PharmiWeb.com
WEBAug 3, 2021 · Here are ten of the top pharmaceutical companies in the country as of 2021…. Pfizer. Pfizer has manufacturing sites in Sydney, Melbourne, Perth and Adelaide, and its products are used in hospitals and pharmacies across the country. Pfizer Australia offers a portfolio containing some of the world’s …
What Does a Pharmaceutical Sales Rep Do? - PharmiWeb.com
WEBAug 2, 2022 · Pharmaceutical Sales Representatives (Reps) are employed by pharmaceutical, biotechnology, or healthcare companies to sell their pharmaceutical products to external stakeholders, e.g., physicians. Rather than making direct sales, they are tasked with influencing and educating these stakeholders on the company’s products, acting as a reliable ...
Which Job Board is the Best for Finding a Pharma Job?
WEBMay 27, 2021 · A job board for pharmaceutical, biotechnology and life sciences roles with positions in the UK, USA, Europe, Australasia, and Asia. Out of 1,392 vacancies, NextPharmaJob.com has 801 jobs in the UK, 75 in Germany, and 1,321 in total across Europe. 333 of these roles are in Clinical Development.
Merck and Sanofi’s First and Only Six-in-One Pediatric …
WEBJun 2, 2021 · VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed as part of a U.S.-based partnership between Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the global vaccines business ...
BELLUS Health Announces Positive Results from its Phase 1 ...
WEBApr 5, 2023 · Once-daily Extended-Release formulation demonstrated equivalent bioavailability to twice-daily Immediate Release formulation. Extended-Release formulation was well tolerated, with the safety profile consistent with previous camlipixant trials and no taste-related adverse events reported
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing ...
WEBTAMPA, FL, August 20, 2024 (Newswire.com) - Promising results with Telomir-1 Demonstrates Potential in Promoting Life Quality and Longevity in Senior Dogs ("Telomir" or the "Company"), a pre-clinical-stage company seeking to lead developments in longevity science through the treatment of age-related conditions, is proud to announce that its novel small molecule, Telomir-1, was recently ...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
WEBMay 31, 2024 · mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes. CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower ...
Guidance for Preparing Standard Operating Procedures (SOPs)
WEBJul 18, 2023 · A Standard Operating Procedure is a documented set of step-by-step of instructions that outline the approved methods and practices for carrying out specific tasks or processes within an organization. In the context of a pharmaceutical company, SOPs play a crucial role in ensuring quality, compliance, and safety across a company's entire ...
Unleashing Strategic Excellence with Competitive Intelligence in ...
WEBAug 22, 2023 · In the fast-paced and ever-changing pharmaceutical landscape, where complexities, risks, rewards, and returns run high, strategic excellence requires superior decision-making. In this article, we describe the role of competitive intelligence, dispel misconceptions, address challenges, and highlight its advantages ...